Concepedia

Ana Elvira Farfán-García

AE

9

Publications

186

Citations

9

H-Index

2014

Active since

Affiliations

Universidad De Santander(Current)

University at Buffalo, State University of New York

Vanderbilt University

Industrial University of Santander

Ana Elvira Farfán-García is an author at Universidad De Santander specializing in drug resistance, antibiotics, and clinical microbiology.

ORCID

Top concepts

Publications per year

2014–2023

9

Publications

9

Etiology of acute gastroenteritis among children less than 5 years of age in Bucaramanga, Colombia: A case-control study

Ana Elvira Farfán-García, Aamer Imdad, Chengxian Zhang et al. · PLoS neglected tropical diseases · 2020 · 53 citations · Full text

Antimicrobial activity of Ib-M peptides against Escherichia coli O157: H7

Sergio Prada-Prada, Johanna Marcela Flórez-Castillo, Ana Elvira Farfán-García et al. · PLoS ONE · 2020 · 39 citations · Full text

, , +19

Epidemiology, Risk Factors and Genotypes of HBV in HIV-Infected Patients in the Northeast Region of Colombia: High Prevalence of Occult Hepatitis B and F3 Subgenotype Dominance

Henry Bautista‐Amorocho, Yeny Zulay Castellanos Domínguez, Laura Andrea Rodríguez-Villamizar et al. · PLoS ONE · 2014 · 23 citations · Full text

Ib-M6 Antimicrobial Peptide: Antibacterial Activity against Clinical Isolates of Escherichia coli and Molecular Docking

Johanna Marcela Flórez-Castillo, Paola Rondón-Villareal, J.L. Ropero-Vega et al. · Antibiotics · 2020 · 14 citations · Full text

Immobilization Systems of Antimicrobial Peptide Ib−M1 in Polymeric Nanoparticles Based on Alginate and Chitosan

Carlos Enrique Osorio-Alvarado, J.L. Ropero-Vega, Ana Elvira Farfán-García et al. · Polymers · 2022 · 14 citations · Full text

Rows per page

1–5 of 9